APA (7th ed.) Citation

Talor, E., Tímár, J., Lavin, P., Cipriano, J., Markovic, D., Ladányi, A., . . . Hao, S. (2025). Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma –the IT-MATTERS study. Pathology oncology research, 31, 1612084. https://doi.org/10.3389/pore.2025.1612084

Chicago Style (17th ed.) Citation

Talor, Eyal, et al. "Neoadjuvant Leukocyte Interleukin Injection Immunotherapy Improves Overall Survival in Low-risk Locally Advanced Head and Neck Squamous Cell Carcinoma –the IT-MATTERS Study." Pathology Oncology Research 31 (2025): 1612084. https://doi.org/10.3389/pore.2025.1612084.

MLA (9th ed.) Citation

Talor, Eyal, et al. "Neoadjuvant Leukocyte Interleukin Injection Immunotherapy Improves Overall Survival in Low-risk Locally Advanced Head and Neck Squamous Cell Carcinoma –the IT-MATTERS Study." Pathology Oncology Research, vol. 31, 2025, p. 1612084, https://doi.org/10.3389/pore.2025.1612084.